A new study reports high cholesterol may contribute to the risk of developing ALS. The findings suggest cholesterol lowering drugs, such as statins, could help to prevent the onsite of the neurodegenerative disease.
Researchers have identified the gene STMN2 as a novel biomarker and potential drug target for ALS.
Researchers report a brain computer interface can enable those with paralysis to directly operate tablet technology just by thinking about cursor movements and clicks.
Researchers have identified the normal function of C9orf72, a gene commonly implicated in ALS and FTD.
Researchers report activating microglia may help reduce the imbalance between neuroprotection and neurotoxicity for neurodegenerative diseases.
A new study provides new clues for the links between aging and neurodegenerative diseases.
A new method reveals some ALS affected neurons display hypo-excitability. Researchers say these changes most likely represent early steps in the disease progression.
Researchers shed light on how stress granules, enzymes linked to a range of neurodegenerative diseases, are formed and how they can be reduced.
Tongue range motion is reduced while lower lip and jaw motion is increased in people who suffer dysarthria associated with ALS. The findings may help develop new therapies to help those with ALS improve their speech, researchers say.
A new collaborative study has helped researchers to uncover some of the earliest molecular events in ALS.
Researchers reveal a small region of Ataxin-2, a protein implicated in long term memory, may drive the progression of ALS.
A new immunotherapy treatment for ALS patients is not only safe, but can also help slow the progression of the disease, researchers report.
